Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust Portfolio Holdings

Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust

  • $7.63 Billion
  • Q1 2024

Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust has filed its 13F form on April 18, 2024 for Q1 2024 where it was disclosed a total value porftolio of $7.63 Billion distributed in 23 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $715M, Amazon Com Inc with a value of $685M, Visa Inc. with a value of $670M, Berkshire Hathaway Inc with a value of $482M, and Apple Inc. with a value of $480M.

Examining the 13F form we can see an increase of $158M in the current position value, from $7.47B to 7.63B.

Below you can find more details about Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust portfolio as well as his latest detailed transactions.

Portfolio value $7.63 Billion
Technology: $2.62 Billion
Financial Services: $1.42 Billion
Consumer Cyclical: $1.26 Billion
Healthcare: $1.02 Billion
Communication Services: $959 Million
Consumer Defensive: $350 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.09T
$715 Million 9.38% of portfolio
1,700,000
Q1 2024 Reduced 8.11%
$1.8T
$685 Million 8.99% of portfolio
3,800,000
Q1 2024 Reduced 18.45%
$445B
$670 Million 8.78% of portfolio
2,400,000
Q4 2021 Added 43.71%
$376B
$482 Million 6.32% of portfolio
760
Q3 2023 Reduced 5.0%
$3.09T
$480 Million 6.29% of portfolio
2,800,000
Q3 2023 Reduced 3.45%
$39.4B
$413 Million 5.42% of portfolio
3,000,000
Q1 2024 Reduced 9.09%
$53.7B
$392 Million 5.14% of portfolio
4,100,000
Q4 2023 Added 16.81%
$133B
$381 Million 5.0% of portfolio
500,000
Q1 2024 Reduced 12.66%
$178B
$381 Million 5.0% of portfolio
1,100,000
Q2 2020 Added 307.41%
$207B
$363 Million 4.76% of portfolio
720,000
Q4 2023 Reduced 10.0%
$179B
$355 Million 4.66% of portfolio
3,125,000
Q4 2023 Added 15.74%
$238B
$350 Million 4.59% of portfolio
2,000,000
Q3 2022 Reduced 4.76%
$191B
$299 Million 3.93% of portfolio
6,000,000
Q2 2022 Reduced 7.69%
$1.06T
$274 Million 3.59% of portfolio
1,800,000
Q4 2023 Reduced 10.0%
$1.03T
$272 Million 3.56% of portfolio
1,800,000
Q4 2023 Reduced 10.0%
$383B
$269 Million 3.53% of portfolio
1,700,000
Q4 2023 Reduced 19.05%
$120B
$235 Million 3.08% of portfolio
2,500,000
Q3 2023 Added 19.05%
$207B
$198 Million 2.6% of portfolio
2,735,900
Q2 2023 Reduced 8.37%
$46.3B
$145 Million 1.9% of portfolio
5,300,000
Q1 2023 Reduced 4.76%
Linde PLC
-
$0 0.0% of portfolio
-
Q1 2023 New
Neumora Therapeutics Inc.
-
$0 0.0% of portfolio
-
Q4 2023 Reduced -0.0%
Maplebear Inc
-
$0 0.0% of portfolio
-
Q3 2023 New

Summary

  • Portfolio
  • No. of Stocks 23
  • Current Value $7.63 Billion
  • Prior Value $7.47 Billion
  • Filing
  • Period Q1 2024
  • Filing Date April 18, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust Portfolio

Follow Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust, based on Form 13F filings with the SEC.

News

Stay updated on Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email